← Back

Wire · opportunities

Pharma Pulse: AstraZeneca-BMS Speculation Cools, Drones Land in Pharmacy, Agentic AI Hits 3PL

Published

6 August 2026

Topic

opportunities

Sectors

Health

Geography

United States

Source

Read at pharmaceuticalcommerce.com

Verified

Fusion42 · 30 August 2026 · Fusion42 review

AstraZeneca and Bristol Myers Squibb deny merger talks amid previous speculation, while drone delivery programs advance into live pharmaceutical use. Kenco deploys agentic AI across 3PL operations, and TailorMed partners with WeInfuse to enhance medication access in infusion workflows.

This Wire brief sits within Fusion42's coverage of Health.

◆ The Wire takeaway

Pharma supply chains are shifting as drone delivery becomes a real patient-facing service and AI automates 3PL operations. If you work in pharma logistics or patient access, these tech adoptions open doors to new service offerings and speed advantages.

Coverage

1 source · 6 Aug 2026

Related on Wire

Topics

Healthpharmaceuticalsdrone-deliveryagentic-ai3plmedication-access